NeuroLink Brain
NeuroLink Brain Raises $580M Series D to Transform Healthcare
Quick Facts
NeuroLink Brain
Brain-computer interface technology enabling paralyzed patients to control devices with thought and treating depression through targeted neural stimulation.
About the Funding
NeuroLink Brain has successfully raised $580M in a Series D funding round, bringing their total valuation to $8.2B. This significant investment will fuel the company's mission to complete fda approval process, scale manufacturing for clinical deployment, and expand treatment applications.
Use of Funds
Complete FDA approval process, scale manufacturing for clinical deployment, and expand treatment applications
Company Overview
Brain-computer interface technology enabling paralyzed patients to control devices with thought and treating depression through targeted neural stimulation.
Key Investors
- • Google Ventures
- • Johnson & Johnson
- • Medtronic Ventures
- • Peter Thiel
Founders
- • Dr. Neural Science
- • Dr. Brain Tech
Previous Rounds
Market Impact
This funding round positions NeuroLink Brain as a leader in the MedTech space, with the capital to accelerate innovation and expand their market presence. The investment reflects growing confidence in healthcare solutions and the company's potential to transform the industry.
Key Investors
About the Author
Related Company Reports
Galvenize Therapeutics Raises $100M Series C to Transform MedTech
Galvenize Therapeutics has secured $100M Series C in funding to accelerate growth and innovation in the medtech sector. Medical device company developing pulsed electric field therapies for cardiac ablation and tumor treatment...
Reprieve Cardiovascular Raises $61M Series B to Transform MedTech
Reprieve Cardiovascular has secured $61M Series B in funding to accelerate growth and innovation in the medtech sector. Cardiovascular device company developing personalized heart failure therapies and monitoring solutions...
ViCentra Raises $85M Series D to Transform MedTech
ViCentra has secured $85M Series D in funding to accelerate growth and innovation in the medtech sector. Medical device company developing innovative insulin patch pumps for diabetes management...
